from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2816c/-

LFCtreatmentdescriptionclass of inhibitor

-0.519

Amikacinug/mL Amikacintranslation

-1.366

Cap5-10ug/mL Capreomycintranslation

-1.192

Rox10-50 ug/mL Roxithromycintranslation

-0.638

SM2-5 ug/mL Streptomycintranslation

-1.095

Tet5-10 ug/mL Tetracyclinetranslation

0.450

Rif0.2-5ug/mL Rifampicintranscription

-0.979

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.186

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.530

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.798

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.345

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.491

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.483

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.365

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.295

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.319

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.895

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.450

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.347

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.340

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.355

KCN5-20 ug/mL Potassium cyaniderespiration

0.449

NaN30.2-2 mM Sodium aziderespiration

1.177

Nigericin50 uM Nigericinrespiration

0.964

TRC10-150 ug/mL Triclosanrespiration

1.933

TRZ10-25 ug/mL Thioridazinerespiration

0.803

Valinomycin0.5-10 uM Valinomycinrespiration

0.139

ZnSO42 mM ZnSO4respiration

-0.730

menadione6-10 ug/mL Menadionerespiration

-0.345

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.782

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.472

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.726

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.685

NRP_1Non-replicating persistence stage 1dosRassociated

-0.371

Amp0.2mg/mL AmpicillincellWall

-0.606

Cephalexin20-100 ug/mL CephalexincellWall

-0.799

Cerulenin0.32-5 ug/mL CerulenincellWall

0.711

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.032

EMB10-20 ug/mL EthambutolcellWall

-0.365

Eta12-40 ug/mL EthionamidecellWall

-0.519

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.522

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.153

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.240

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.921

BZA0.12 mg/mL BenzamidearomaticAmides

0.558

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.216

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.321

H2O24 mM hydrogen peroxideDNAdamaging

-0.788

Levo10 ug/mL LevofloxacinDNAdamaging

0.041

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.193

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.603

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.235

UVUV-irradiationDNAdamaging

-1.158

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.771

Antimycin12.5-50 ug/mL Antimycin A?

-1.049

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.100

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.222

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.527

PA8240.2-2 ug/mL PA-824?

0.387

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.114

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.213

Verapamil50 uM Verapamil?

0.145

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.494

methoxatin10-20 ug/mL Methoxatin?